$STE (Steris Plc)

$STE {{ '2016-08-09T18:10:18+0000' | timeago}} • Webcast

$STE said it ended 1Q17 with $242.4MM of cash and approx. $1.55Bil in total debt. The company continues to reduce its debt through EBITDA leverage, which was about 2.6 times at 1Q17 end. The company's DSO was 62 days at quarter end, an increase of 5 days as compared to last year. Free cash flow for the quarter was $49.5MM.

$MYL {{ '2017-10-17T16:40:23+0000' | timeago}} • Announcement

$MYL announced that the United States District Court for the Eastern District of Texas issued a decision finding all asserted claims of the patents relating to Restasis invalid. The Court recognized that $AGN's patent protection for Restasis ended in 2014.

$JNJ {{ '2017-10-17T13:40:49+0000' | timeago}} • Webcast

Only months after promising investors a slew of new blockbuster drugs, $JNJ said it has decided to discontinue clinical trials for two of its drugs. Sirukumab, for the treatment of rheumatoid arthritis, and talacotuzumab, for the treatment of myeloid leukemia, are the drugs that have been discontinued.

$JNJ {{ '2017-10-17T12:09:28+0000' | timeago}} • Infographic

$JNJ Johnson & Johnson Earnings AlphaGraphic: Q3 2017 Highlights

$UNH {{ '2017-10-17T11:55:37+0000' | timeago}} • Infographic

$UNH UnitedHealth Earnings AlphaGraphics: Q3 2017 Highlights

$JNJ {{ '2017-10-17T11:47:16+0000' | timeago}} • Announcement

$JNJ raised its sales and adjusted earnings guidance for FY17. The New Brunswick, NJ-based healthcare giant now expects sales for the period to be in the range of $76.1 - 76.5Bil, verses the prior guidance of $75.8 - 76.1Bil. Adjusted earnings is anticipated to be $7.25 - $7.30 per share, compared to the prior guidance of $7.12 - $7.22 per share.

$JNJ {{ '2017-10-17T11:36:50+0000' | timeago}} • Announcement

Kicking off the earnings season in healthcare sector, $JNJ reported 10.3% growth in its sales to $19.7Bil in 3Q17. Adjusted earnings also rose double digits to $5.2Bil, or $1.90 per share, driven by strong growth in Pharma unit, as well as Actelion acquisition. On a GAAP basis, earnings fell 12% to $3.8Bil, or $1.37 per share.

$AGN {{ '2017-10-16T21:26:34+0000' | timeago}} • Announcement

Drugmaker $AGN gets an adverse effect from the U.S. District Court for the Eastern District of Texas. The judge invalidated Allergan's Restasis patent deal, which was signed with the Mohawk Tribe in the last month. Allergan plans to appeal the ruling. Restasis, a dry-eye treatment drug,  generated $1.5Bil of revenues for Allergan in 2016.

$MASI {{ '2017-10-16T21:02:15+0000' | timeago}} • Announcement

$MASI announced that the bankruptcy court in San Diego has issued final judgment holding that Sotera Wireless Employees misappropriated Masimo trade secrets. The misappropriation stems from two former Masimo employees, James Welch and David Hunt, copying thousands of confidential Masimo documents and using Masimo’s trade secrets to benefit Sotera.

$JNJ {{ '2017-10-16T14:43:30+0000' | timeago}} • Announcement

$JNJ said Janssen Biotech Inc. has received FDA approval for an expanded indication for STELARA for the treatment of adolescents with plaque psoriasis.

$XRAY {{ '2017-10-16T12:23:03+0000' | timeago}} • Announcement

$XRAY appointed two new leadership team members effective immediately. Nick Alexos joins the company as EVP, Chief Administrative Officer, reporting to Mark Thierer, Interim CEO. Additionally, Keith Ebling joins as EVP, General Counsel & Secretary, also reporting to Mark Thierer. He replaces Jonathan Friedman who resigned from the company.

$AGN {{ '2017-10-12T22:44:22+0000' | timeago}} • Announcement

$AGN, which inked a controversial patent deal with Mohawk Tribe, reached a patent litigation settlement on its dry eye treatment drug Restasis with InnoPharma, a unit of $PFE. The litigation, which was filed in Sept. 2015 by Allergan, will be withdrawn and Allergan will grant license to InnoPharma to market Restasis from Feb. 2024 or earlier.

$PII {{ '2017-10-12T20:51:31+0000' | timeago}} • Announcement

$PII announced that Chris Musso will join the company on November 6 as President, Off-Road Vehicles (ORV), reporting directly to Chairman and CEO Scott Wine. $PII’s Snow business will also report to Musso.

$AIT {{ '2017-10-11T16:46:06+0000' | timeago}} • Announcement

Engineering firm $AIT has named Robert Pagano and Joe Raver to its Board of Directors. Pagano has been serving as President and CEO of Watts Water Technologies since 2014. Raver has served as President and CEO of Hillenbrand since 2013.

$HRC {{ '2017-10-11T12:47:11+0000' | timeago}} • Announcement

$HRC provided an update on its Aspen Surgical facility in Las Piedras, Puerto Rico, where the company manufactures Bard-Parker surgical scalpels and blades. The company confirmed that the facility sustained minor structural damage, temporary loss of power and minimal water damage due to Hurricane Maria.

$AGN {{ '2017-10-10T18:02:39+0000' | timeago}} • Announcement

FDA accepts to review $AGN's New Drug Application seeking approval for ulipristal acetate, an investigational drug for the treatment of abnormal bleeding in women with uterine fibroids. Allergan expects the action date to occur in 1H18. According to the Agency for Healthcare Research and Quality (AHRQ), 26MM women in U.S. have got uterine fibroids.

$PG {{ '2017-10-10T16:14:25+0000' | timeago}} • Announcement

$PG's shareholders have voted to elect all 11 of its highly qualified Directors to its Board. Nelson Peltz of Trian was not elected to the Board. This is based on a preliminary vote count provided by its proxy solicitors following its 2017 Annual Meeting.

$VRX {{ '2017-10-10T14:50:38+0000' | timeago}} • Infographic

$VRX's progress towards paying down a huge debt of $5Bil before Feb 2018.

$HRC {{ '2017-10-10T14:13:09+0000' | timeago}} • Announcement

$HRC's Welch Allyn subsidiary said its home medical devices will now be offered as part of $HON’s remote patient monitoring platform. The Welch Allyn Home 1700 Series Blood Pressure Monitor and Welch Allyn Home Weight Scale will be offered as standard peripherals with Honeywell Life Care Solution's Genesis Touch remote patient monitoring kits.

$JNJ {{ '2017-10-05T13:58:49+0000' | timeago}} • Announcement

Animas Corp., a $JNJ Diabetes Care Companies, plans to discontinue the manufacturing and sale of Animas Vibe and OneTouch Ping insulin pumps, close operations and exit the insulin pump business. Animas has selected $MDT as its partner-of-choice to facilitate a seamless transition for patients, caregivers and healthcare providers.

$HRC {{ '2017-10-05T12:06:47+0000' | timeago}} • Announcement

Chairman of $HRC Board Rolf Classon will not stand for re-election to the BoD when his current term expires on March 6, 2018. The Board plans to appoint current independent director William Dempsey to this role if he is re-elected by shareholders. The company also elected Gary Ellis, retired CFO and SVP of $MDT, to its BoD, effective Oct 5, 2017.

Recent Transcripts

AIT (Applied Industrial Technologies, Inc.)
Friday, August 11 2017 - 2:00pm
MYL (Mylan N.V.)
Wednesday, August 9 2017 - 2:00pm
XRAY (DENTSPLY International Inc.)
Wednesday, August 9 2017 - 12:30pm
CCXI (ChemoCentryx, Inc.)
Tuesday, August 8 2017 - 9:00pm
NVAX (Novavax, Inc.)
Tuesday, August 8 2017 - 8:30pm
STE (Steris Plc)
Tuesday, August 8 2017 - 2:00pm
IVC (Invacare Corporation)
Tuesday, August 8 2017 - 12:30pm
ENDP (Endo International plc)
Tuesday, August 8 2017 - 12:30pm
VRX (Valeant Pharmaceuticals International, Inc.)
Tuesday, August 8 2017 - 12:00pm
MSA (MSA Safety Incorporated)
Friday, August 4 2017 - 12:30pm
SRCL (Stericycle, Inc.)
Thursday, August 3 2017 - 9:00pm
AGN (Allergan plc)
Thursday, August 3 2017 - 12:30pm
MASI (Masimo Corporation)
Wednesday, August 2 2017 - 8:30pm
WMGI (Wright Medical Group N.V.)
Wednesday, August 2 2017 - 8:30pm
KTWO (K2M Group Holdings, Inc.)
Tuesday, August 1 2017 - 9:00pm
KAMN (Kaman Corporation)
Tuesday, August 1 2017 - 12:30pm
IDXX (IDEXX Laboratories, Inc.)
Tuesday, August 1 2017 - 12:30pm
HRC (Hill-Rom Holdings, Inc.)
Friday, July 28 2017 - 12:30pm
MTD (Mettler-Toledo International Inc.)
Thursday, July 27 2017 - 8:30pm
JCI (Johnson Controls Inc.)
Thursday, July 27 2017 - 3:00pm

AlphaGraphics you may like